Navigation Links
Qteros and UMass Amherst Announce the Issuance of a U.S. Patent for Production of Ethanol From a Unique Microorganism, the Q Microbe(TM)
Date:3/23/2010

"Integration of our unique Q Microbe™ technology into a cellulosic ethanol plant design allows producers the opportunity to dramatically reduce the capital and operating costs associated with a biomass-to-ethanol process," states Kevin A. Gray, PhD, Senior Vice President and Chief Technology Officer of Qteros. According to Gray, "While traditional cellulosic ethanol processes require numerous production steps, including the addition of costly exogenous enzymes, use of the Q Microbe™ lowers costs by simultaneously hydrolyzing polysaccharides into simple sugars and fermenting all of these sugars into desirable products in a single-tank operation."

"The Q Microbe™ technology offers numerous important advantages over other ethanol-producing microorganisms, which we believe provides the operational foundation for profitable, commercial-scale cellulosic ethanol production," states John A. McCarthy, Jr., President and CEO of Qteros. "This patent underscores the significance and the unique nature of our technology and represents an important milestone that will further our progress toward commercialization of a robust, low-cost CBP platform for cellulosic ethanol production."

Specific advantages of this patented technology include, the natural production of all enzymes required to digest biomass into its component sugars, the ability to ferment polymeric forms of sugar resulting in decreased pretreatment costs and more efficient ethanol production, the
'/>"/>

SOURCE Qteros, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Biofuels Technology Leader Qteros Names Mick Sawka Vice President, Business Development
2. Biofuels Technology Leader Qteros Names Industry Veteran John McCarthy President and Chief Executive Officer
3. Cellulosic Biofuels Leader Qteros Adds Key Positions
4. Qteros Employees Planting Special Trees in Celebration of International Day of Climate Action, October 24, 2009
5. UMass Boston's Venture Development Center Announces New Bio-Science Partner
6. UMass Boston Opens Venture Development Center to Expand R&D Activity
7. University of Massachusetts Amherst and ADVENTUS Recognize Future Environmental Science Leaders
8. Genedata Announces Five-Year Agreement Extension with Kluyver Centre for Genomics of Industrial Fermentation
9. Cell Therapy Group Announces Expansion of Consultants Roster in Regenerative Medicine
10. The Protein Structure Initiative announces free OpenHelix tutorial and training materials for the Structural Genomics Knowledgebase (SGKB)
11. Kendle Announces New Revolving Credit Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... 29, 2015  Caris Life Sciences® today ... small cell cervical cancer (SCCC) that shows ... the company,s panomic, comprehensive tumor profiling service, identified ... may explain sensitivities and resistance to common ... certain biomarkers may guide treatment strategies in ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Earlier this ... the promotion of hair regrowth in adult men and ... I-II or Norwood Hamilton classifications of IIa-V and Fitzpatrick ... industry plagued by products that over-promise and under-deliver, FDA ... renewing faith and confidence among more than 80 million ...
(Date:3/27/2015)... 2015  Neogen Corporation (NASDAQ: NEOG ) announced ... trading plan in accordance with Securities and Exchange Commission ... of Neogen Corporation, is a minority owner of this ... Herbert does not have control of this ... is only for a portion of the shares owned ...
(Date:3/27/2015)... 2015 Working in collaboration with the ... London , Richmond Pharmacology is the first centre ... study for an investigational RNAi therapeutic being developed for the ... nerves and heart. Read press release ... Based at St Georges University of London ...
Breaking Biology Technology:Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 2Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 3Dr. Robert Leonard Applauds FDA Clearance of Capillus272Pro™ Hair Loss Laser Cap 2Neogen CEO adopts 10b5-1 Trading Plan 2
... today announced that Solomon Steiner, Chairman and CEO of ... Hidden Gems,Conference in New York, NY on October 8th ... a link to a live audio webcast of the,presentation ... http://www.biodel.com . A replay of the presentation will be ...
... Awarded for Chemistry and Automation as well as Immunoassay ... ... 4 Siemens Medical Solutions,Diagnostics, (http://www.siemens.com/diagnostics ), announced ... Systems, (http://www.medassets.com ), a,Group Purchasing Organization (GPO) and ...
... Dillahunty, Vice,President, Intellectual Property of Oncolytics Biotech Inc. (TSX: ... Company at BIO,InvestorForum 2007 on Thursday, October 11 at ... Palace Hotel in San Francisco from October 9-11, 2007. ... is available on the,company,s website at http://www.oncolyticsbiotech.com . ...
Cached Biology Technology:Biodel Inc. to Present at Natixis Bleichroeder Hidden Gems Conference on October 8, 2007 2MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions 2MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions 3Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007 2
(Date:3/24/2015)...   NexID Biometrics LLC, whose spoof-mitigation technology ... announced the beginning of shipments of version 2.0 of ... company, based in Potsdam, N.Y. , ... which began here today at the Walter E. Washington ... its SDK boosts the accuracy rate range to 96.5 ...
(Date:3/23/2015)... OXFORD, Conn. , Mar. 23, 2015 NXT-ID, Inc. ... authentication company focused on the growing mobile commerce market, announces ... a new advertising campaign on CNBC television starting March 30 ... ads will commence airing in New York ... Executive Officer said: "We are excited about our new ad ...
(Date:3/19/2015)... , March 19, 2015  NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market, announces its biometric ... news clip that aired this week on Washington ... In a segment "The Next Great Thing", host ... new way to pay, and ,a really big breakthrough in ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
... April 10, 2013, New York, NY A dozen ... advancements in basic and clinical cancer research at this ... 2013. Progress in immunotherapy and epigenetics led the program ... therapy. "With new immunotherapy agents available ...
... at which a child with autism is diagnosed is ... or she exhibits, new research from the University of ... nonverbal communication and repetitive behaviors, were associated with earlier ... study in the April issue of the Journal ...
... Department of Energy,s (DOE) National Renewable Energy Laboratory (NREL) ... of real-world performance from solar facilities across the country. ... Performance and Reliability Clearinghouse (O-SPaRC) will give the private ... public capital. "The O-SPaRC dataset will provide the ...
Cached Biology News:Ludwig advancements in immunotherapy and epigenetics top scientific program at AACR 2In autism, age at diagnosis depends on specific symptoms 2
...
DryStrip aligners, 4. Category: Electrophoresis Systems & Standards & Reagents, IEF & SDS-PAGE & 2-D Electrophoresis, Multiphor II Kits & Components and Accessories....
Newborn Calf Serum US Origin...
Immunogen: Peptide corresponding to amino acid residues from the N-terminal region of human thyroid hormone receptor, alpha1/alpha2-isotype. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: